Anagrelide Capsule
Product Images NDC 13668-453

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Anagrelide (NDC 13668-453). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Da9106e7 80de 4af7 8d38 C1ac79b6c1ee 01)

Chemical structure of anagrelide showing a bicyclic system with two chlorine atoms, a hydrazine group, and an imidazolone ring with a hydrochloride and water molecule attached.*

FDA Label Image

Image (Da9106e7 80de 4af7 8d38 C1ac79b6c1ee 02)

A line graph showing the mean platelet count (in thousands per microliter) over time during anagrelide therapy for patients with thrombocytosis secondary to myeloproliferative disorders. The x-axis represents time on treatment in weeks (up to 208 weeks), and the y-axis shows the mean platelet count ranging from 300 to 1200. The graph illustrates a decrease in platelet count from baseline through treatment, with corresponding subject numbers listed below the timeline. A table beneath the graph summarizes mean platelet counts and subject numbers at various weeks and years during treatment.*

FDA Label Image

Image (Da9106e7 80de 4af7 8d38 C1ac79b6c1ee 03)

FDA Label Image

05 Labels (Da9106e7 80de 4af7 8d38 C1ac79b6c1ee 04)

Anagrelide Capsules USP 0.5 mg oral capsules label for a 30-capsule bottle. The label indicates it is a platelet-reducing agent and includes NDC 13668-453-30. Manufactured by Torrent Pharmaceuticals Limited. The label contains dosage information, storage instructions, and warnings to keep out of reach of children. Barcode and Rx only designation are also visible.*

FDA Label Image

1 mg Lab (Da9106e7 80de 4af7 8d38 C1ac79b6c1ee 05)

Label for Anagrelide Capsules, USP 1 mg by Torrent Pharmaceuticals Limited. The label indicates the product contains 30 capsules and is classified as a platelet-reducing agent for oral use. It includes dosage instructions, storage conditions, and manufacturer information with a barcode on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.